|
Name |
Octadecanedioic acid
|
| Molecular Formula | C18H34O4 | |
| IUPAC Name* |
octadecanedioic acid
|
|
| SMILES |
C(CCCCCCCCC(=O)O)CCCCCCCC(=O)O
|
|
| InChI |
InChI=1S/C18H34O4/c19-17(20)15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18(21)22/h1-16H2,(H,19,20)(H,21,22)
|
|
| InChIKey |
BNJOQKFENDDGSC-UHFFFAOYSA-N
|
|
| Synonyms |
Octadecanedioic acid; 871-70-5; 1,18-Octadecanedioic acid; 1,16-Hexadecanedicarboxylic acid; Octadecane-1,18-dioic acid; RSZ6PQ0QQJ; Hexadecanedicarboxylic acid; 1,18-Octadecadioic acid; Octadecanedioate; MFCD00142369; 1,18-Octadecanedioate; 1,16-Hexadecanedicarboxylate; UNII-RSZ6PQ0QQJ; ODDA; 18-octadecanedioic acid; OCTADECANEDIOICACID; SCHEMBL35775; AMY042; DTXSID1074331; CHEBI:133086; 1,16-hexadecane dicarboxylic acid; BCP32531; ZINC5178630; LMFA01170029; AKOS015839857; CS-W005178; GS-3421; HY-W005178; AC-32514; SY025879; FT-0700803; O0222; 871O705; A842023; 1,18-Octadecadioic acid;Octadecane-1,18-dioic acid; Q27288272
|
|
| CAS | 871-70-5 | |
| PubChem CID | 70095 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 314.5 | ALogp: | 6.4 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 17 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 74.6 | Aromatic Rings: | 0 |
| Heavy Atoms: | 22 | QED Weighted: | 0.341 |
| Caco-2 Permeability: | -5.478 | MDCK Permeability: | 0.00004330 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.02 | 20% Bioavailability (F20%): | 0.876 |
| 30% Bioavailability (F30%): | 0.986 |
| Blood-Brain-Barrier Penetration (BBB): | 0.005 | Plasma Protein Binding (PPB): | 98.97% |
| Volume Distribution (VD): | 0.448 | Fu: | 0.61% |
| CYP1A2-inhibitor: | 0.065 | CYP1A2-substrate: | 0.15 |
| CYP2C19-inhibitor: | 0.02 | CYP2C19-substrate: | 0.075 |
| CYP2C9-inhibitor: | 0.131 | CYP2C9-substrate: | 0.995 |
| CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.053 |
| CYP3A4-inhibitor: | 0.003 | CYP3A4-substrate: | 0.005 |
| Clearance (CL): | 1.49 | Half-life (T1/2): | 0.769 |
| hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.047 |
| Drug-inuced Liver Injury (DILI): | 0.041 | AMES Toxicity: | 0.004 |
| Rat Oral Acute Toxicity: | 0.01 | Maximum Recommended Daily Dose: | 0.018 |
| Skin Sensitization: | 0.705 | Carcinogencity: | 0.137 |
| Eye Corrosion: | 0.983 | Eye Irritation: | 0.969 |
| Respiratory Toxicity: | 0.516 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000110 | ![]() |
0.776 | D0E4WR | ![]() |
0.565 | ||
| ENC000356 | ![]() |
0.731 | D07ILQ | ![]() |
0.564 | ||
| ENC000357 | ![]() |
0.712 | D0O1PH | ![]() |
0.506 | ||
| ENC000050 | ![]() |
0.687 | D00AOJ | ![]() |
0.500 | ||
| ENC000282 | ![]() |
0.658 | D0Z5SM | ![]() |
0.432 | ||
| ENC000608 | ![]() |
0.653 | D00FGR | ![]() |
0.427 | ||
| ENC000466 | ![]() |
0.642 | D0Z5BC | ![]() |
0.400 | ||
| ENC000280 | ![]() |
0.627 | D00STJ | ![]() |
0.397 | ||
| ENC001304 | ![]() |
0.619 | D0P1RL | ![]() |
0.385 | ||
| ENC001553 | ![]() |
0.617 | D05ATI | ![]() |
0.363 | ||